Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab

Massimo Gentile, Tait D Shanafelt, Gianluigi Reda, Francesca Romana Mauro, Katja Zirlik, Stefania Ciolli, Luca Laurenti, Maria Ilaria Del Principe, Davide Rossi, Nicola Di Renzo, Stefano Molica, Francesco Angrilli, Marta Coscia, Annalisa Chiarenza, Annamaria Giordano, Giovanna Cutrona, Kari G Chaffee, Sameer A Parikh, Giuseppina Uccello, Idanna InnocentiGiovanni Tripepi, Graziella D'Arrigo, Ernesto Vigna, Anna Grazia Recchia, Yair Herishanu, Lev Shvidel, Tamar Tadmor, Agostino Cortelezzi, Giovanni Del Poeta, Gianluca Gaidano, Francesco Di Raimondo, Antonino Neri, Manlio Ferrarini, Robin Foà, Aaron Polliack, Fortunato Morabito

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1869-1873
Number of pages5
JournalLeukemia
Volume32
Issue number8
DOIs
Publication statusPublished - Aug 2018

Cite this

Gentile, M., Shanafelt, T. D., Reda, G., Mauro, F. R., Zirlik, K., Ciolli, S., Laurenti, L., Del Principe, M. I., Rossi, D., Di Renzo, N., Molica, S., Angrilli, F., Coscia, M., Chiarenza, A., Giordano, A., Cutrona, G., Chaffee, K. G., Parikh, S. A., Uccello, G., ... Morabito, F. (2018). Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab. Leukemia, 32(8), 1869-1873. https://doi.org/10.1038/s41375-018-0100-6